UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Unfractionated heparin dosing in obese patients

International journal of clinical pharmacy, 2020-04, Vol.42 (2), p.462-473

2020

Volltextzugriff (PDF)

Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes

Journal of Psychopharmacology, 2016-03, Vol.30 (3), p.227-236

2016

Volltextzugriff (PDF)

Management and Pharmacological Treatment of Peripheral Arterial Disease

Journal of pharmacy practice, 2024-05, p.8971900241250084-8971900241250084

2024

Volltextzugriff (PDF)

Evaluation of an interactive education workshop on hospital pharmacists' ethical reasoning: an observational study

BMC medical ethics, 2024-07, Vol.25 (1), p.81-12, Article 81

2024

Volltextzugriff (PDF)

Learning on the run - a qualitative, longitudinal study of pharmacy educators' experiences implementing a hospital pharmacy residency program

BMC medical education, 2022-06, Vol.22 (1), p.430-430, Article 430

2022

Volltextzugriff (PDF)

Metformin reduces 12-month change in body weight among people newly commenced on clozapine: a retrospective naturalistic cohort study

Therapeutic advances in psychopharmacology, 2021, Vol.11, p.20451253211000609-20451253211000609

2021

Volltextzugriff (PDF)

Estimation of cardiac QTc intervals in people prescribed antipsychotics: a comparison of correction factors

Therapeutic advances in psychopharmacology, 2022, Vol.12, p.204512532211049-20451253221104947

2022

Volltextzugriff (PDF)

CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine

Therapeutic advances in psychopharmacology, 2021, Vol.11, p.20451253211045248-20451253211045248

2021

Volltextzugriff (PDF)

Experiences and learnings of pharmacists, students, and clinical assistants working collaboratively in a COVID-19 vaccination clinic: a qualitative study

Exploratory research in clinical and social pharmacy, 2023-03, Vol.9, p.100241-100241, Article 100241

2023

Volltextzugriff (PDF)

Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: study protocol for a pilot randomised controlled trial

BJPsych open, 2015-06, Vol.1 (1), p.67-73

2015

Volltextzugriff (PDF)

Does Switching Antipsychotics Ameliorate Weight Gain in Patients With Severe Mental Illness? A Systematic Review and Meta-analysis

Schizophrenia bulletin, 2021-07, Vol.47 (4), p.948-958

2021

Volltextzugriff (PDF)

Clozapine in primary care

Australian Prescriber, 2017-12, Vol.40 (6), p.231-236

2017

Volltextzugriff (PDF)

Letter to the editor: Comments on “Prevalence and predictors of QTc prolongation in patients seen in a clozapine clinic in a real-world setting in Australia”

Schizophrenia research, 2024-02, Vol.264, p.370-371

2024

Volltextzugriff (PDF)

Comment On: “Stratifying Therapeutic Enoxaparin Dose in Morbidly Obese Patients by BMI Class: A Retrospective Cohort Study”

Clinical drug investigation, 2020-03, Vol.40 (3), p.287-288

2020

Volltextzugriff (PDF)

Clozapine use and prevalence in Australia 2016–2020

Australian and New Zealand journal of psychiatry, 2022-03, Vol.56 (3), p.305-306

2022

Volltextzugriff (PDF)

Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity

Journal of thrombosis and thrombolysis, 2019-10, Vol.48 (3), p.387-393

2019

Volltextzugriff (PDF)

Bazett's correction formula overestimates the corrected QT among patients with antipsychotic induced tachycardia

Schizophrenia research, 2021-05, Vol.231, p.22-23

2021

Volltextzugriff (PDF)

Treatment of clozapine‐associated obesity and diabetes with exenatide in adults with schizophrenia: A randomized controlled trial (CODEX)

Diabetes, obesity & metabolism, 2018-04, Vol.20 (4), p.1050-1055

2018

Volltextzugriff (PDF)

Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993–2014

Psychopharmacology, 2018-07, Vol.235 (7), p.1915-1921

2018

Volltextzugriff (PDF)

Evaluation of the duration of dual‐antiplatelet therapy after percutaneous coronary intervention: a retrospective audit on the compliance with guidelines or cardiologist recommendation

Journal of pharmacy practice and research, 2022-02, Vol.52 (1), p.42-48

2022

Volltextzugriff (PDF)

Comment On: "Stratifying Therapeutic Enoxaparin Dose in Morbidly Obese Patients by BMI Class: A Retrospective Cohort Study"/Response

Clinical drug investigation, 2020-03, Vol.40 (3), p.287-290

2020

Volltextzugriff (PDF)

Real-world comparative effectiveness of dalteparin and enoxaparin for venous thromboembolism prophylaxis

Blood coagulation & fibrinolysis, 2024-04, Vol.35 (3), p.101-107

2024

Volltextzugriff (PDF)

A retrospective review examining intravenous iron infusion dosing methods

Journal of pharmacy practice and research, 2021-06, Vol.51 (3), p.225-230

2021

Volltextzugriff (PDF)

Clozapine-induced myocarditis: Separating the wheat from the chaff

Australian and New Zealand journal of psychiatry, 2015-02, Vol.49 (2), p.188-188

2015

Volltextzugriff (PDF)

Evaluation of the Quality and Safety of Venous Thromboembolism Prophylaxis Among Gastroenterology Inpatients at a Tertiary Hospital in Australia

Hospital pharmacy (Philadelphia), 2023-12, Vol.58 (6), p.595-604

2023

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(27)
Pharmacology & Pharmacy
(15)
Calculus Of Variations
(14)
Differential Equations
(14)
Humans
(13)
Infinite Series
(13)
Psychiatry
(13)
Antipsychotics
(9)
Obesity
(9)
Schizophrenia
(9)
Clozapine
(7)
Clozapine - Adverse Effects
(6)
Antidiabetics
(5)
Antipsychotic Agents - Adverse Effects
(5)
Female
(5)
Male
(5)
Middle Aged
(5)
Patients
(5)
Pharmacy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Unfractionated heparin dosing in obese patients

Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes

Management and Pharmacological Treatment of Peripheral Arterial Disease

Evaluation of an interactive education workshop on hospital pharmacists' ethical reasoning: an observational study

Learning on the run - a qualitative, longitudinal study of pharmacy educators' experiences implementing a hospital pharmacy residency program

Metformin reduces 12-month change in body weight among people newly commenced on clozapine: a retrospective naturalistic cohort study

Estimation of cardiac QTc intervals in people prescribed antipsychotics: a comparison of correction factors

CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine

Experiences and learnings of pharmacists, students, and clinical assistants working collaboratively in a COVID-19 vaccination clinic: a qualitative study

Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: study protocol for a pilot randomised controlled trial

Does Switching Antipsychotics Ameliorate Weight Gain in Patients With Severe Mental Illness? A Systematic Review and Meta-analysis

Clozapine in primary care

Letter to the editor: Comments on “Prevalence and predictors of QTc prolongation in patients seen in a clozapine clinic in a real-world setting in Australia”

Comment On: “Stratifying Therapeutic Enoxaparin Dose in Morbidly Obese Patients by BMI Class: A Retrospective Cohort Study”

Clozapine use and prevalence in Australia 2016–2020

Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity

Bazett's correction formula overestimates the corrected QT among patients with antipsychotic induced tachycardia

Treatment of clozapine‐associated obesity and diabetes with exenatide in adults with schizophrenia: A randomized controlled trial (CODEX)

Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993–2014

Evaluation of the duration of dual‐antiplatelet therapy after percutaneous coronary intervention: a retrospective audit on the compliance with guidelines or cardiologist recommendation

Comment On: "Stratifying Therapeutic Enoxaparin Dose in Morbidly Obese Patients by BMI Class: A Retrospective Cohort Study"/Response

Real-world comparative effectiveness of dalteparin and enoxaparin for venous thromboembolism prophylaxis

A retrospective review examining intravenous iron infusion dosing methods

Clozapine-induced myocarditis: Separating the wheat from the chaff

Evaluation of the Quality and Safety of Venous Thromboembolism Prophylaxis Among Gastroenterology Inpatients at a Tertiary Hospital in Australia

Suchergebnisse filtern